A-Fib Far More Common Than Previously Thought
In the first national estimate in two decades, UCSF reports that three times as many Americans have atrial fibrillation than previous estimates.
Read More
Author: Alyx Arnett
Investigational Drug Improves Range of Exercise Performance Measures in Heart Patients
In a new analysis, investigators probed multiple exercise response patterns before and after exposure to the drug in patients with hypertrophic obstructive cardiomyopathy.
Read More
Regular Mobile Phone Use Linked to Increased Cardiovascular Disease Risk. Why?
A new study investigates the association between mobile phone use, risk of heart diseases, and modifiable lifestyle factors.
Read More
How to Gauge Women’s Heart Disease Risk 30 Years Out
A long-term study reveals that certain markers measured from a single blood draw can predict a woman’s future cardiovascular risk.
Read More
SGLT2 Inhibitor Empagliflozin Safe and Effective for Heart Attack Patients
Empagliflozin was found to be safe and reduce heart failure events for heart attack patients and can be initiated shortly after hospitalization without risk to kidney function, even in patients with chronic kidney disease.
Read More